- €6.39bn
- €5.99bn
- €5.37bn
- 99
- 40
- 50
- 71
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,880 | 4,635 | 4,703 | 5,165 | 5,373 |
Cost of Revenue | |||||
Gross Profit | 1,401 | 1,416 | 1,555 | 1,716 | 1,826 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4,988 | 4,410 | 4,322 | 4,701 | 4,849 |
Operating Profit | -108 | 225 | 381 | 464 | 524 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -126 | 197 | 358 | 447 | 499 |
Provision for Income Taxes | |||||
Net Income After Taxes | -187 | 108 | 300 | 375 | 405 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -171 | 96.8 | 305 | 401 | 393 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -171 | 96.8 | 305 | 401 | 393 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.553 | 0.915 | 2.02 | 2.44 | 2.64 |
Dividends per Share |